Studying how frailty affects outcomes in COPD
Part of Heart & circulation, Lungs & breathing clinical trials.
This study looks at whether frailty (how weak or vulnerable someone is) changes the risk of heart-related events and death in people with COPD. It may help doctors better predict who is at higher risk and tailor care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and have COPD for at least 1 year
- Your COPD has been stable (no COPD flare-ups in the past 30 days) or you haven’t been hospitalized for any reason in the past 3 months
- You have a smoking history of at least 10 pack-years
- You can clearly understand and sign the study consent form
- You do not have lung scarring from interstitial lung disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how frailty affects the course of chronic diseases and how chronic diseases affect frailty. It may help understand aging-related conditions better.
This study looks at how different factors—like health, mental well-being, and social support—work together to predict frailty in older adults. The goal is to better understand frailty in men and women, which may help doctors provide more personalized care.
This trial looks at “frailty,” meaning reduced strength and resilience, in older adults with coronary artery disease who are getting heart care. It may help doctors better understand which patients are more at risk and how care decisions could be improved.
This study looks at people with COPD or ILD who also show signs of frailty. It aims to understand how frailty and muscle loss (sarcopenia) affect their care and use of medical resources over time.
This study uses a simple questionnaire to understand how frailty affects people living with lung cancer. It helps doctors learn more about your overall health and how to better support you.
This trial looks at whether “frailty” (how weak or vulnerable someone is) changes short- and long-term outcomes after surgery. It may help doctors better predict who could benefit from extra support before and after surgery.
Hear when a new Role of Frailty in COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.